{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:57:35Z","timestamp":1782917855729,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00399-026-01150-9","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:36:00Z","timestamp":1778240160000},"page":"168-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management von Komplikationen bei kardialen Device-Operationen","Management of complications associated with cardiac device procedures"],"prefix":"10.1007","volume":"37","author":[{"given":"Yuriy","family":"Hrytsyna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaik","family":"Nersesian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Starck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"1150_CR1","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.jacep.2017.05.007","volume":"3","author":"DJ Cantillon","year":"2017","unstructured":"Cantillon\u00a0DJ, Exner\u00a0DV, Badie\u00a0N et\u00a0al (2017) Complications and Health Care Costs Associated With Transvenous Cardiac Pacemakers in a Nationwide Assessment. JACC Clin Electrophysiol 3:1296\u20131305","journal-title":"JACC Clin Electrophysiol"},{"key":"1150_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/europace\/euaa367","volume":"23","author":"H Burri","year":"2021","unstructured":"Burri\u00a0H, Starck\u00a0C, Auricchio\u00a0A et\u00a0al (2021) EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS). Europace 23:983\u20131008","journal-title":"Europace"},{"key":"1150_CR3","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1161\/CIRCEP.111.969105","volume":"5","author":"ML Bernard","year":"2012","unstructured":"Bernard\u00a0ML, Shotwell\u00a0M, Nietert\u00a0PJ et\u00a0al (2012) Meta-analysis of bleeding complications associated with cardiac rhythm device implantation. Circ Arrhythm Electrophysiol 5:468\u2013474","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1150_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.hroo.2022.05.012","volume":"3","author":"KG Tarakji","year":"2022","unstructured":"Tarakji\u00a0KG, Korantzopoulos\u00a0P, Philippon\u00a0F et\u00a0al (2022) Risk factors for hematoma in patients undergoing cardiac device procedures: A\u00a0WRAP-IT trial analysis. Heart Rhythm O2 3:466\u2013473","journal-title":"Heart Rhythm O2"},{"key":"1150_CR5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/joa3.12769","volume":"38","author":"SK Fensman","year":"2022","unstructured":"Fensman\u00a0SK, Grove\u00a0EL, Johansen\u00a0JB et\u00a0al (2022) Predictors of pocket hematoma after cardiac implantable electronic device surgery: A nationwide cohort study. J\u00a0Arrhythm 38:748\u2013755","journal-title":"J Arrhythm"},{"key":"1150_CR6","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jacc.2016.01.009","volume":"67","author":"V Essebag","year":"2016","unstructured":"Essebag\u00a0V, Verma\u00a0A, Healey\u00a0JS et\u00a0al (2016) Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study. J\u00a0Am Coll Cardiol 67:1300\u20131308","journal-title":"J Am Coll Cardiol"},{"key":"1150_CR7","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","volume":"368","author":"DH Birnie","year":"2013","unstructured":"Birnie\u00a0DH, Healey\u00a0JS, Wells\u00a0GA et\u00a0al (2013) Pacemaker or defibrillator surgery without interruption of anticoagulation. N\u00a0Engl J Med 368:2084\u20132093","journal-title":"N Engl J Med"},{"key":"1150_CR8","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1093\/eurheartj\/ehy413","volume":"39","author":"DH Birnie","year":"2018","unstructured":"Birnie\u00a0DH, Healey\u00a0JS, Wells\u00a0GA et\u00a0al (2018) Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2). European heart journal 39:3973\u20133979","journal-title":"European heart journal"},{"key":"1150_CR9","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","volume":"42","author":"M Glikson","year":"2021","unstructured":"Glikson\u00a0M, Nielsen\u00a0JC, Kronborg\u00a0MB et\u00a0al (2021) 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. European heart journal 42:3427\u20133520","journal-title":"European heart journal"},{"key":"1150_CR10","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","volume":"39","author":"J Steffel","year":"2018","unstructured":"Steffel\u00a0J, Verhamme\u00a0P, Potpara\u00a0TS et\u00a0al (2018) The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. European heart journal 39:1330\u20131393","journal-title":"European heart journal"},{"key":"1150_CR11","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1161\/CIRCULATIONAHA.106.678664","volume":"116","author":"D Klug","year":"2007","unstructured":"Klug\u00a0D, Balde\u00a0M, Pavin\u00a0D et\u00a0al (2007) Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 116:1349\u20131355","journal-title":"Circulation"},{"key":"1150_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ASW.0000000000000201","volume":"37","author":"C Valls A","year":"2024","unstructured":"Valls A\u00a0C, M\u00a0N, C\u00a0D et\u00a0al (2024) Efficacy of Hypothermic Compression Bandages in Cardiac Device Surgical Wounds: A Randomized Controlled Trial. Adv Skin Wound Care 37:1\u20137","journal-title":"Adv Skin Wound Care"},{"key":"1150_CR13","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJMoa1901111","volume":"380","author":"KG Tarakji","year":"2019","unstructured":"Tarakji\u00a0KG, Mittal\u00a0S, Kennergren\u00a0C et\u00a0al (2019) Antibacterial Envelope to Prevent Cardiac Implantable Device Infection. N\u00a0Engl J Med 380:1895\u20131905","journal-title":"N Engl J Med"},{"key":"1150_CR14","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1093\/eurheartj\/ehaa010","volume":"41","author":"C Blomstr\u00f6m-Lundqvist","year":"2020","unstructured":"Blomstr\u00f6m-Lundqvist\u00a0C, Traykov\u00a0V, Erba\u00a0PA et\u00a0al (2020) European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European heart journal 41:2012\u20132032","journal-title":"European heart journal"},{"key":"1150_CR15","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/cid\/cix181","volume":"64","author":"EM Tan","year":"2017","unstructured":"Tan\u00a0EM, Desimone\u00a0DC, Sohail\u00a0MR et\u00a0al (2017) Outcomes in Patients With Cardiovascular Implantable Electronic Device Infection Managed With Chronic Antibiotic Suppression. Clin Infect Dis 64:1516\u20131521","journal-title":"Clin Infect Dis"},{"key":"1150_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/pace.13300","volume":"41","author":"AJ Greenspon","year":"2018","unstructured":"Greenspon\u00a0AJ, Eby\u00a0EL, Petrilla\u00a0AA et\u00a0al (2018) Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection. Pacing Clin Electrophysiol 41:495\u2013503","journal-title":"Pacing Clin Electrophysiol"},{"key":"1150_CR17","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/europace\/euv053","volume":"17","author":"KA Polyzos","year":"2015","unstructured":"Polyzos\u00a0KA, Konstantelias\u00a0AA, Falagas\u00a0ME (2015) Risk factors for cardiac implantable electronic device infection: a\u00a0systematic review and meta-analysis. Europace 17:767\u2013777","journal-title":"Europace"},{"key":"1150_CR18","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1016\/j.jacc.2018.09.068","volume":"72","author":"AD Krahn","year":"2018","unstructured":"Krahn\u00a0AD, Longtin\u00a0Y, Philippon\u00a0F et\u00a0al (2018) Prevention of Arrhythmia Device Infection Trial: The PADIT Trial. J\u00a0Am Coll Cardiol 72:3098\u20133109","journal-title":"J Am Coll Cardiol"},{"key":"1150_CR19","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.amjcard.2012.01.360","volume":"109","author":"F Viganego","year":"2012","unstructured":"Viganego\u00a0F, O\u2019donoghue\u00a0S, Eldadah\u00a0Z et\u00a0al (2012) Effect of early diagnosis and treatment with percutaneous lead extraction on survival in patients with cardiac device infections. The American journal of cardiology 109:1466\u20131471","journal-title":"The American journal of cardiology"},{"key":"1150_CR20","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.hrthm.2021.12.023","volume":"19","author":"JZ Lee","year":"2022","unstructured":"Lee\u00a0JZ, Majmundar\u00a0M, Kumar\u00a0A et\u00a0al (2022) Impact of timing of transvenous lead removal on outcomes in infected cardiac implantable electronic devices. Heart Rhythm 19:768\u2013775","journal-title":"Heart Rhythm"},{"key":"1150_CR21","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1001\/jamacardio.2023.3379","volume":"8","author":"SD Pokorney","year":"2023","unstructured":"Pokorney\u00a0SD, Zepel\u00a0L, Greiner\u00a0MA et\u00a0al (2023) Lead Extraction and Mortality Among Patients With Cardiac Implanted Electronic Device Infection. JAMA Cardiol 8:1165\u20131173","journal-title":"JAMA Cardiol"},{"key":"1150_CR22","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.hrthm.2011.05.015","volume":"8","author":"KY Le","year":"2011","unstructured":"Le\u00a0KY, Sohail\u00a0MR, Friedman\u00a0PA et\u00a0al (2011) Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm 8:1678\u20131685","journal-title":"Heart Rhythm"},{"key":"1150_CR23","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.hrthm.2005.06.011","volume":"2","author":"S Mahapatra","year":"2005","unstructured":"Mahapatra\u00a0S, Bybee\u00a0KA, Bunch\u00a0TJ et\u00a0al (2005) Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart Rhythm 2:907\u2013911","journal-title":"Heart Rhythm"},{"key":"1150_CR24","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/pace.12472","volume":"37","author":"F Migliore","year":"2014","unstructured":"Migliore\u00a0F, Zorzi\u00a0A, Bertaglia\u00a0E et\u00a0al (2014) Incidence, management, and prevention of right ventricular perforation by pacemaker and implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol 37:1602\u20131609","journal-title":"Pacing Clin Electrophysiol"},{"key":"1150_CR25","doi-asserted-by":"crossref","unstructured":"Yam M, Tsang B, Katsikeris F et\u00a0al. (2025) Persistent iatrogenic interventricular septal defect after left bundle branch area pacing. Heart Rhythm","DOI":"10.1016\/j.hrthm.2025.08.046"},{"key":"1150_CR26","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1093\/europace\/euac105","volume":"24","author":"PH Waddingham","year":"2022","unstructured":"Waddingham\u00a0PH, Elliott\u00a0J, Bates\u00a0A et\u00a0al (2022) Iatrogenic cardiac perforation due to pacemaker and defibrillator leads: a\u00a0contemporary multicentre experience. Europace 24:1824\u20131833","journal-title":"Europace"},{"key":"1150_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/europace\/euy165","volume":"21","author":"AP Benz","year":"2019","unstructured":"Benz\u00a0AP, Vamos\u00a0M, Erath\u00a0JW et\u00a0al (2019) Cephalic vs. subclavian lead implantation in cardiac implantable electronic devices: a\u00a0systematic review and meta-analysis. Europace 21:121\u2013129","journal-title":"Europace"},{"key":"1150_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00399-023-00954-3","volume":"34","author":"E Martens","year":"2023","unstructured":"Martens\u00a0E, Sommer\u00a0P, Johnson\u00a0V et\u00a0al (2023) Ven\u00f6se Zugangswege in der kardialen Devicetherapie. Herzschrittmachertherapie + Elektrophysiologie 34:250\u2013255","journal-title":"Herzschrittmachertherapie + Elektrophysiologie"},{"key":"1150_CR29","first-page":"1193","volume":"19","author":"NY Chan","year":"2017","unstructured":"Chan\u00a0NY, Kwong\u00a0NP, Cheong\u00a0AP (2017) Venous access and long-term pacemaker lead failure: comparing contrast-guided axillary vein puncture with subclavian puncture and cephalic cutdown. Europace 19:1193\u20131197","journal-title":"Europace"},{"key":"1150_CR30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jacep.2023.11.020","volume":"10","author":"F Vitali","year":"2024","unstructured":"Vitali\u00a0F, Malag\u00f9\u00a0M, Bianchi\u00a0N et\u00a0al (2024) Ultrasound-Guided Venous Axillary Access Versus Standard Fluoroscopic Technique for Cardiac Lead Implantation: ZEROFLUOROAXI Randomized Trial. JACC Clin Electrophysiol 10:554\u2013565","journal-title":"JACC Clin Electrophysiol"},{"key":"1150_CR31","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1177\/11297298211054621","volume":"24","author":"S D\u2019arrigo","year":"2023","unstructured":"D\u2019arrigo\u00a0S, Perna\u00a0F, Annetta\u00a0MG et\u00a0al (2023) Ultrasound-guided access to the axillary vein for implantation of cardiac implantable electronic devices: A systematic review and meta-analysis. J\u00a0Vasc Access 24:854\u2013863","journal-title":"J Vasc Access"},{"key":"1150_CR32","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1159\/000490179","volume":"97","author":"J Schnell","year":"2019","unstructured":"Schnell\u00a0J, Beer\u00a0M, Eggeling\u00a0S et\u00a0al (2019) Management of Spontaneous Pneumothorax and Post-Interventional Pneumothorax: German S3 Guideline. Respiration 97:370\u2013402","journal-title":"Respiration"},{"key":"1150_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1056\/NEJMoa1910775","volume":"382","author":"SGA Brown","year":"2020","unstructured":"Brown\u00a0SGA, Ball\u00a0EL, Perrin\u00a0K et\u00a0al (2020) Conservative versus Interventional Treatment for Spontaneous Pneumothorax. N\u00a0Engl J Med 382:405\u2013415","journal-title":"N Engl J Med"},{"key":"1150_CR34","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/j.jacc.2023.04.017","volume":"81","author":"EG Ferro","year":"2023","unstructured":"Ferro\u00a0EG, Kramer\u00a0DB, Li\u00a0S et\u00a0al (2023) Incidence, Treatment, and Outcomes of Symptomatic Device Lead-Related Venous Obstruction. J\u00a0Am Coll Cardiol 81:2328\u20132340","journal-title":"J Am Coll Cardiol"},{"key":"1150_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-018-0664-5","volume":"20","author":"J Donnelly","year":"2018","unstructured":"Donnelly\u00a0J, Gabriels\u00a0J, Galmer\u00a0A et\u00a0al (2018) Venous Obstruction in Cardiac Rhythm Device Therapy. Curr Treat Options Cardiovasc Med 20:64","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"1150_CR36","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1540-8159.2010.03026.x","volume":"34","author":"JD Daniels","year":"2011","unstructured":"Daniels\u00a0JD, Sun\u00a0S, Zafereo\u00a0J et\u00a0al (2011) Preventing shoulder pain after cardiac rhythm management device implantation: a randomized, controlled study. Pacing Clin Electrophysiol 34:672\u2013678","journal-title":"Pacing Clin Electrophysiol"},{"key":"1150_CR37","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/europace\/euad043","volume":"25","author":"H Burri","year":"2023","unstructured":"Burri\u00a0H, Jastrzebski\u00a0M, Cano \u00d3 et\u00a0al (2023) EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS). Europace 25:1208\u20131236","journal-title":"Europace"},{"key":"1150_CR38","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.hrthm.2021.03.015","volume":"18","author":"RG Hauser","year":"2021","unstructured":"Hauser\u00a0RG, Gornick\u00a0CC, Abdelhadi\u00a0RH et\u00a0al (2021) Major adverse clinical events associated with implantation of a leadless intracardiac pacemaker. Heart Rhythm 18:1132\u20131139","journal-title":"Heart Rhythm"},{"key":"1150_CR39","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJMoa1511643","volume":"374","author":"D Reynolds","year":"2016","unstructured":"Reynolds\u00a0D, Duray\u00a0GZ, Omar\u00a0R et\u00a0al (2016) A Leadless Intracardiac Transcatheter Pacing System. N\u00a0Engl J Med 374:533\u2013541","journal-title":"N Engl J Med"},{"key":"1150_CR40","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1056\/NEJMoa2300080","volume":"388","author":"RE Knops","year":"2023","unstructured":"Knops\u00a0RE, Reddy\u00a0VY, Ip\u00a0JE et\u00a0al (2023) A Dual-Chamber Leadless Pacemaker. N\u00a0Engl J Med 388:2360\u20132370","journal-title":"N Engl J Med"},{"key":"1150_CR41","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/eurheartj\/ehae101","volume":"45","author":"MF El-Chami","year":"2024","unstructured":"El-Chami\u00a0MF, Garweg\u00a0C, Clementy\u00a0N et\u00a0al (2024) Leadless pacemakers at 5\u2011year follow-up: the Micra transcatheter pacing system post-approval registry. European heart journal 45:1241\u20131251","journal-title":"European heart journal"},{"key":"1150_CR42","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.663807","volume":"115","author":"T Kleemann","year":"2007","unstructured":"Kleemann\u00a0T, Becker\u00a0T, Doenges\u00a0K et\u00a0al (2007) Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of \u3009 10 years. Circulation 115:2474\u20132480","journal-title":"Circulation"},{"key":"1150_CR43","doi-asserted-by":"crossref","unstructured":"Provid\u00eancia R, Kramer DB, Pimenta D et\u00a0al. (2015) Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A\u00a0Meta-Analysis of Observational Studies. J\u00a0Am Heart Assoc 4","DOI":"10.1161\/JAHA.115.002418"},{"key":"1150_CR44","doi-asserted-by":"publisher","first-page":"e503","DOI":"10.1016\/j.hrthm.2017.09.001","volume":"14","author":"FM Kusumoto","year":"2017","unstructured":"Kusumoto\u00a0FM, Schoenfeld\u00a0MH, Wilkoff\u00a0BL et\u00a0al (2017) 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm 14:e503\u2013e551","journal-title":"Heart Rhythm"},{"key":"1150_CR45","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.jacc.2005.02.037","volume":"45","author":"G Lin","year":"2005","unstructured":"Lin\u00a0G, Nishimura\u00a0RA, Connolly\u00a0HM et\u00a0al (2005) Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J\u00a0Am Coll Cardiol 45:1672\u20131675","journal-title":"J Am Coll Cardiol"},{"key":"1150_CR46","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/jce.16227","volume":"35","author":"C Shanafelt","year":"2024","unstructured":"Shanafelt\u00a0C, Middour\u00a0TG, Ibrahim\u00a0R et\u00a0al (2024) Outcomes of tricuspid regurgitation after lead extraction. J\u00a0Cardiovasc Electrophysiol 35:929\u2013938","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1150_CR47","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.4244\/EIJ-JAA-202501","volume":"21","author":"JC Deharo","year":"2025","unstructured":"Deharo\u00a0JC, Dreyfus\u00a0J, Bongiorni\u00a0MG et\u00a0al (2025) Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society. EuroIntervention 21:1317\u20131337","journal-title":"EuroIntervention"},{"key":"1150_CR48","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1161\/CIR.0000000000001187","volume":"149","author":"LM Baddour","year":"2024","unstructured":"Baddour\u00a0LM, Z\u00a0EG, M\u00a0RS et\u00a0al (2024) Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association: Endorsed by the International Society for Cardiovascular Infectious Diseases. Circulation 149:e201\u2013e216","journal-title":"Circulation"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-026-01150-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00399-026-01150-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-026-01150-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:39:09Z","timestamp":1782916749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00399-026-01150-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1150"],"URL":"https:\/\/doi.org\/10.1007\/s00399-026-01150-9","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Starck gibt Zahlungen als Vortragshonorare, Beratungshonorare, Beiratshonorare sowie als Ausschussmitglied bei Angiodynamics, Abiomed, Atricure, Medtronic, Philips, Biotronik, Merit Medical und Cook Medical an, ferner Forschungsmittel f\u00fcr seine Abteilung oder Einrichtung von Cook Medical, Hylomorph, Atricure und Angiodynamics. Y.\u00a0Hrytsyna G.\u00a0Nersesian geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}